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Abstract
The Bluetongue virus serotype 8 (BTV-8) strain, which emerged in Europe in 2006, had an unusually high ability to cause
foetal infection in pregnant ruminants. Other serotypes of BTV had already been present in Europe for more than a decade,
but transplacental transmission of these strains had never been demonstrated. To determine whether transplacental
transmission is a unique feature of BTV-8 we compared the incidence and pathological consequences of transplacental
transmission of BTV-8 to that of BTV-1. Nine pregnant ewes were infected with either BTV-8 or BTV-1. The BTV strains used
for the infection were field strains isolated on embryonated chicken eggs and passaged twice on mammalian cells. Blood
samples were taken to monitor the viraemia in the ewes. Four weeks after the infection, the foetuses were examined for
pathological changes and for the presence of BTV. BTV-8 could be demonstrated in 12 foetuses (43%) from 5 ewes (56%).
%). BTV-1 was detected in 14 foetuses (82%) from 6 ewes (67%). Pathological changes were mainly found in the central
nervous system. In the BTV-8 group, lympho-histiocytic infiltrates, gliosis and slight vacuolation of the neuropil were found.
BTV-1infection induced a severe necrotizing encephalopathy and severe meningitis, with macroscopic hydranencephaly or
porencephaly in 8 foetuses. In our experimental setting, using low passaged virus strains, BTV-1 was able to induce
transplacental transmission to a higher incidence compared to BTV-8, causing more severe pathology.
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Introduction
Bluetongue virus (BTV), an orbivirus (Reoviridae), is the causative
agent of bluetongue, a severe haemorrhagic disease of ruminants
(primarily sheep) characterized by fever, oedema, mucosal erosions
and coronitis [1,2]. BTV has a double-stranded RNA genome,
comprised of 10 segments that encode structural proteins VP1 to
VP7 and non-structural proteins NS1 to NS4 [3,4]. BTV is a
heterogeneous virus species: 24 serotypes (determined by the outer
shell protein VP2 and, to a lesser extent, VP5) have been described
to date; recent isolates from Switzerland and Kuwait have been
proposed as 25thand 26th serotype [5,6]. Even within one serotype,
large genetic and phenotypic variations can be observed related to
geographical origin : BTV topotypes [7,8]. The ability of BTV
strains to reassort genome segments adds to the variability between
virus strains [9–11] and may even result in BTV strains with
enhanced virulence [12] or increased abilities to adapt to new
ecological zones [10].
The main BTV transmission route is through biting midges of
the Culicoides species. Other routes, like transplacental transmis-
sion, are probably of less epidemiological importance. However,
the impact of transplacental transmission on agro-economic
parameters such as fertility and reproductive performance can
be substantial [13,14]. Transplacental transmission of BTV had
already been described in 1955 [15], when vaccination of
pregnant dams with a live embryonated-chicken-egg-passage
attenuated BTV vaccine led to the birth of lambs with serious
nervous system defects. This has been reproduced in both sheep
and cattle in an experimental setting, using various BTV serotypes
[16–20]. In most of these experiments, BTV strains were used,
which had been given a high number of in vitro -or in ovo- passages,
In contrast, low-passaged strains did not cross the placenta [21].
This led to the assumption that transplacental transmission of
BTV was exclusively associated with cell culture- or egg-adapted
BTV strains [22].
During the BTV-8 outbreak in Europe (2006–2009), transpla-
cental transmission of BTV-8 was reported in several countries;
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with incidence ratios up to 33% [23]. Prior to this BTV-8
outbreak, BTV-1, BTV-2, BTV-4, BTV-9, and BTV-16 had
already been present in southern Europe [9]. Except for the live
BTV-2 and BTV-9 vaccine strains, for which a 2.4% incidence of
vaccine virus positive foetuses has been demonstrated [24],
transplacental transmission of these other BTV strains has not
been described in Europe.
The aim of our study was to compare the incidence and
pathological consequences of transplacental transmission of BTV-
8 to that of another European BTV strain: BTV-1 [25].
We demonstrated that a European isolate of BTV-1, which has
had one passage on embryonated chicken eggs (ECE) and two
passages on mammalian cells, is also capable of establishing an
infection in ovine foetuses. The incidence of transplacental
transmission of BTV-1 was at least as high as that of BTV-8.
Moreover, BTV-1 induced severe central nervous system defects
such as hydranencephaly, whereas these lesions were not observed
in the BTV-8 infected foetuses.
Materials and Methods
Ethics statement
The experiment was performed in accordance with European
Community guidelines and national laws on animal experiments.
The design of the experiment was approved by the MSD Animal
and Human Health Committee on the Ethics of Animal
Experiments (‘Dierexperimentencommissie’, which is required by
national legislation to include both MSD AH employees and
independent members) prior to the start (Permit Number: BTV
11.054). All efforts were made to minimize animal discomfort.
Animals
Twenty Swifter ewes were synchronized using medroxyproges-
terone acetate intravaginal sponges (Veramix, Pfizer) in January
2012. On the day of removal of the sponges, the ewes received 750
IU pregnant mare serum gonadotrophin (Folligonan, MSDAH)
and three rams were added to the flock. The ewes were checked
for pregnancy at regular intervals. Nine weeks after mating, the
ewes were transferred from the conventional stables to two rooms
of the MSD Animal Health (MSDAH) isolation facilities. Each
room contained nine BTV inoculated ewes and one control ewe.
The animal room was treated with cyfluthrin (Solfac, Bayer)
shortly before housing of the animals.
Blood samples, taken from the ewes just before BTV-infection,
were free from Bluetongue virus, ruminant pestiviruses and
antibodies against those viruses. Blood samples taken prior to
the synchronization had high Schmallenberg virus (SBV) neutral-
izing antibody titres, indicating that an SBV infection had taken
place prior to the synchronization of the ewes.
Design of the experiment
Twenty pregnant ewes were enrolled in the experiment. At
approximately 70–75 days gestation, nine randomly chosen ewes
were inoculated with 4.0 log10 TCID50/10 ml BTV-8, nine ewes
received 4.0 log10 TCID50/10 ml BTV-1 and two remaining ewes
served as untreated controls. The inocula were administered
subcutaneously in the axillary fold.
The ewes were observed once daily for clinical signs of BTV
infection (including body temperatures) and for signs of abortion.
Blood samples for antibody and virus detection were taken prior to
inoculation and every 2–3 days until the end of the experiment.
Twenty-nine days after inoculation, all ewes were euthanized.
The ewes were inspected for macroscopic lesions and samples of
the spleens were taken for virus isolation. Samples were taken from
the foetuses’ umbilical cord blood, placentomes (one for each
foetus), spleen, liver, kidney, thymus, tongue, cerebrum and
cerebellum. Each of the tissue samples was taken in duplicate: one
sample was fixated in 4% buffered formaldehyde, embedded in
paraffin and stained with haematoxylin and eosin for microscopic
pathology; the other sample was stored at 270uC for virus
isolation. To avoid cross-contamination, the placebo-infected ewes
were autopsied first and the equipment was disinfected between
the sampling of the foetuses.
Inocula
The Bluetongue virus serotype 8 strain was isolated from a
clinically affected ewe during the 2006 epidemic in the Nether-
lands. The BTV-1 strain was isolated from a clinically affected
sheep in Spain (kindly supplied by M. Domingo-Alvarez of the
Centre de Recerca en Sanitat Animal (CReSA), Barcelona, Spain).
Both viruses were isolated on ECE and subsequently passaged
once on baby hamster kidney cells (BHK21) and once on Vero
cells, to obtain virus stocks OvBTV-8 Ver1291007 07K07 and
BTV-1 MSl22092009. The virus stocks were free from bacterial
and viral contaminants. Both virus stocks were diluted in cell
culture medium to a titre of 3.0 log10 TCID50/ml briefly before
the inoculation of the pregnant ewes.
Virus isolation (VI) from blood and tissue samples
EDTA blood samples were washed and sonicated as described
earlier [26]. Approximately 0.5 cm3 of tissue sample was
homogenized in 2 ml culture medium containing antibiotics and
antifungals. A sample of 1 ml of sonicated blood or tissue
homogenate was incubated for 1–1.5 h on a 25 cm2 sub-confluent
(70–90%) monolayer of Vero cells. Subsequently, the sample was
removed and the monolayers were washed once with PBS to
prevent toxicity to the monolayer. The monolayers were incubated
at 37uC and 5% CO2 for 7 days and regularly examined for the
presence of cytopathogenic effect (CPE). If no CPE was visible, the
monolayers were propagated using trypsin and again incubated for
7 days. This step was repeated until three cell culture passages had
been performed.
To determine the BTV serotype of positive VI test samples,
serotype specific PCR tests were performed on the supernatant as
described below.
Detection of viral RNA in blood and cell culture
supernatant
Viral RNA was extracted from duplicates of 200 ml of sample
using the MagNA Pure 96 System extraction robot (Roche
Diagnostics) and the MagNA Pure 96 DNA and Viral NA Small
Volume Kit. RNA was eluted in 50 ml and stored at 270uC until
use.
panBTV RT-qPCR. The real-time reverse transcriptase
polymerase chain reaction (RT-qPCR) designed to detect all
serotypes of BTV was used ([27]with minor modifications). From
each of the RNA extracts, 6 ml was tested using the SuperScript III
Platinum One-Step Quantitative RT-PCR system (Invitrogen).
Individual cycle threshold (Ct) values were determined at the point
at which the level of fluorescence passed a threshold; the PCR
Base Line Subtracted Curve Fit method (CFX96 software,
BioRad) was used to analyse the data. Ct values of duplicates
were averaged; 46.00 was used for calculations when no Ct value
was obtained. Average Ct values were categorized as negative
(Ct$35.00), doubtfully positive (Ct between 30.00 and 35.00) or
positive (Ct,30.00), as described before [28].
BTV-8 and BTV-1 Transplacental Transmission
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Serotype specific RT-qPCRs. For the RT-qPCR to specif-
ically detect either BTV serotype 1 or 8, the LSI VetMax
European BTV typing (1-2-4-6-8-9-11-16) Real Time PCR kit
(Cat. No. BTVEUG, LSI/Life Technologies) was used in accor-
dance with the manufacturer’s instructions.
BTV specific antibody tests
The VMRDH competitive inhibition antibody ELISA was used
in accordance with the manufacturer’s instructions to test for the
presence of BTV-specific antibodies.
Results
Ewes
At the time of the infection, all ewes were free from BTV
(Table 1). All BTV infected ewes were BTV RNA positive at 5
days post infection (dpi), except for ewe 78654 (BTV-8 group),
which was positive at 7 dpi. The BTV infected ewes remained
viraemic until the time point of necropsy, 29 dpi. The non-
infected control ewe (Number 78600) that was housed in the same
pen as the BTV-8 infected ewes remained BTV RNA negative
throughout the experiment. In blood samples from control ewe
78626 (housed together with the BTV-1 infected ewes) BTV RNA
could be demonstrated at 21 and 26 dpi. Presence of BTV at the
time of necropsy was confirmed by isolation of BTV virus from a
sample of the spleen of control ewe 78626; serotype specific RT-
qPCRs confirmed the presence of BTV-1.
All ewes were BTV antibody negative at the time of infection.
Four weeks later, at the time of necropsy, all 18 BTV infected ewes
had formed BTV antibodies. The control ewe in the BTV-8 group
remained negative until the end of the experiment. However, the
control ewe in the BTV-1 group developed antibodies against
BTV (Table 1).
The BTV-8 infection induced mostly mild clinical signs like
fever, rhinitis, conjunctivitis, hyperaemia, and facial oedema. Ewe
78613showed anorexia, dyspnoea, and severe lameness at 18 dpi
and it was euthanized (sodium pentobarbital (Euthazol 40%, AST
Pharma)) for animal welfare reasons.
The BTV-1 infection resulted in more severe clinical signs: 4/9
ewes showed severe dyspnoea, fever, anorexia, foaming at the
mouth, oral lesions, lameness, and facial oedema. Ewe 5566 was
euthanized at 15 dpi because of anorexia and severe respiratory
distress: necropsy showed that the ewe suffered from a multifocal
pneumonia.
Foetuses
Virology. The nine ewes in the BTV-8 group had 28 foetuses;
12 foetuses (43%) from 5 ewes (56%) were positive for BTV in the
Table 1. Presence of Bluetongue virus RNA and BTV antibodies in blood samples of ewes on different days post inoculation.
RT-qPCR at day post infectiona
BTV antibodies
at day post
infectionb
Group Ewe number 0c 5 7 11 14 21 26 29d 0c 29d
BTV8 5572 46.00 33.82 27.13 28.16 28.90 29.12 30.01 28.74 2 +
78612 46.00 24.76 19.76 20.45 23.61 23.48 24.36 23.54 2 +
78613 46.00 31.54 26.19 21.69 22.39 n.s.e n.s. n.s. 2 ns
78618 46.00 22.02 21.82 23.85 25.37 25.66 26.42 25.44 2 +
78648 46.00 23.33 21.44 21.97 23.91 24.25 25.86 23.77 2 +
78653 46.00 31.69 27.30 21.64 21.79 23.81 25.41 25.15 2 +
78654 46.00 35.41 29.45 22.26 24.98 26.00 26.43 25.36 2 +
78676 46.00 22.98 20.71 21.35 21.77 23.27 24.79 25.06 2 +
78678 46.00 29.69 24.62 21.14 21.94 24.39 24.96 23.94 2 +
BTV1 5537 46.00 24.43 19.93 21.43 21.46 23.58 23.08 22.29 2 +
5566 46.00 24.24 19.50 19.86 20.77 n.s. n.s. n.s. 2 ns
5585 46.00 25.23 20.76 23.16 23.21 24.24 23.59 23.59 2 +
78630 46.00 22.85 21.86 21.91 25.40 26.57 25.60 25.37 2 +
78631 46.00 24.12 20.23 19.79 21.53 25.05 24.32 23.66 2 +
78634 46.00 26.23 19.77 19.74 23.82 24.67 23.78 23.12 2 +
78649 46.00 23.74 19.95 19.59 23.69 24.67 23.73 23.51 2 +
78655 46.00 27.73 22.58 19.96 20.46 23.02 23.66 23.68 2 +
78656 46.00 22.85 21.46 20.47 22.12 26.17 26.41 23.47 2 +
Control BTV-8 78600 46.00 46.00 46.00 46.00 46.00 46.00 46.00 46.00 2 2
Control BTV-1 78626 46.00 43.10 46.00 46.00 46.00 25.16 21.70 n.s.f 2 +
aRT-qPCR result: Ct,30 = positive (in bold), 30#Ct,35 =doubtful, Ct$35 = negative.
bBTV antibodies: + antibodies detected; 2: no antibodies detected.
cbefore inoculation,
dat necropsy.
en.s.: no sample.
fno EDTA sample was available from ewe 78626 at the time of necropsy.
However, BTV-1 could be isolated from the spleen sample of this ewe.
doi:10.1371/journal.pone.0081429.t001
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panBTV RT-qPCR on samples of the umbilical cord blood
(Table 2). The positive results of the RT-qPCR were confirmed by
isolation of BTV from the blood and spleen samples. In 11 of 12
positive foetuses, BTV could also be isolated from the cerebrum,
the cerebellum, or both. Serotype specific RT-qPCRs confirmed
the presence of BTV-8 and the absence of BTV-1 in the BTV-8
group. From two of the s foetuses 78613.2 and 78613.3, no
umbilical cord blood samples could be taken, since the blood had
already clotted. However, spleen samples were negative in the VI
test so these foetuses were considered uninfected.
The BTV-8 control ewe 78600 had only one foetus; this foetus
was BTV negative (Table 2).
The nine ewes in the BTV-1 group had 17 foetuses. Six BTV-1
infected ewes (67%) transmitted the virus to their foetuses,
resulting in 14 BTV RT-qPCR positive foetuses (82%). The
positive panBTV RT-qPCR results were confirmed by virus
isolations from the spleen, cerebrum or cerebellum (Table 3).
Serotype specific RT-qPCRs confirmed the presence of BTV-1
and not BTV-8 in the foetuses.
Although the BTV-1 control ewe (No. 78626) became BTV
RNA positive between 14 and 21 dpi, all tests on the tissues of the
foetuses were negative, indicating that the virus was not
transmitted to the foetuses (Table 3).
Pathology. The most prominent macroscopic pathological
findings in the foetuses were central nervous system lesions. In a
normally developed foetal brain, gyral convolutions can already be
seen at this stage (Figure 1). In seven BTV-1 infected foetuses
hydranencephaly was observed: the cerebral hemispheres were
transformed to membranous sacs filled with a clear, reddish fluid.
Occasionally, small islands of remaining cerebral tissue could be
seen in the wall of these membranous sacs (Figure 2). In foetus
Table 2. Presence of Bluetongue infectious virus or RNA in foetal tissues: BTV 8 infected group+commingled control.
Foetal tissues
Umbilical cord blooda Spleen Cerebrum Cerebellum
Group Foetus number VI RT-qPCR VI VI VI
Uninfected controls 78600.1 2 46.00 2 2 2
BTV8 infected 5572.1 2 46.00 2
5572.2 2 46.00 2
5572.3 2 40.75 2
5572.4 2 46.00 2
78612.1 + 16.20 + + +
78612.2 2 46.00 2
78613.1 2 42.52 2
78613.2 n.s. n.s. 2
78613.3 n.s. n.s. 2
78618.1 2 46.00 2
78648.1 2 19.94 + 2 +
78648.2 + 21.57 + + +
78648.3 + 20.54 + + +
78648.4 + 23.88 + + +
78653.1 2 46.00 2
78653.2 2 46.00 2
78653.3 2 42.03 2
78653.4 2 41.72 2
78653.5 2 46.00 2
78654.1 + 16.80 + + +
78654.2 + 17.08 + + +
78654.3 + 27.48 + 2 2
78654.4 + 22.76 + 2 +
78676.1 + 18.06 + + +
78676.2 + 16.27 + + +
78676.3 + 18.30 + + +
78678.1 2 46.00 2
78678.2 2 46.00 2
Total no. of pos samples/no. of samples tested 11/24 12/26 12/28 9/12 11/12
aRT-qPCR result: Ct,30 = positive (in bold), 30#Ct,35 =doubtful, Ct$35 = negative.
Virus isolation (VI): + cpe detected; 2: no cpe detected. ns: no sample.
doi:10.1371/journal.pone.0081429.t002
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78630.2, porencephaly was observed: localized cystic defects in the
cerebral hemispheres (Figure 3).
These severe macroscopic central nervous system deformations
were only seen in foetuses from the BTV-1 group.
To evaluate the incidence of microscopic lesions, the incidence
ratios of microscopic lesions in the BTV-8 positive foetuses, the
BTV-1 positive foetuses, and the negative foetuses were compared
(Figure 4). Inflammation of the central nervous system was the
most prominent microscopic finding in both the BTV-8 and the
BTV-1 infected foetuses.
In the BTV-8 group, the central nervous system lesions
consisted mainly of lympho-histiocytic infiltrates and gliosis. Slight
vacuolation of the neuropil was seen in foetuses 76854.1, 2 and 3.
In the spleen, slight reticular hyperplasia was seen in 1 foetus and
lympho-histiocytic infiltrates in the kidney were seen in 2 foetuses.
In the BTV-1 group, the incidence of microscopic findings was
higher compared to the BTV-8 group (Figure 2); the lesions in the
BTV-1 infected foetuses were more severe. Comparable to the
BTV-8 group, lympho-histiocytic infiltrates were found in the
meninges, but the presence of fibrinous exudate and giant cells
(Figure 5) was unique to the BTV-1 group. In the parenchyma of
the cerebrum and cerebellum, infiltrations of lymphocytes
(Figure 6) and gliosis were found in respectively 13 and 10 of
the 14 foetuses. In addition, large areas of liquefactive necrosis
were seen in five foetuses, associated with giant cells (Figures 7–8),
whereas this was not seen in the BTV-8 infected foetuses and in
the non-infected foetuses (Figure 9). In the plexus choroideus of
foetus 78631.3 (with hydranencephaly, ballooning degeneration of
the epithelium and congestion of blood vessels were observed
(Figure 10). The incidence of lymphoid depletion and reticular
hyperplasia in the spleen was higher in the BTV-1 group.
Discussion
The infection of 9 mid-term pregnant ewes with BTV-8 led to
the transplacental infection of 12 foetuses (43%); 5/9 ewes (56%)
transmitted the virus to their foetuses.
Yet, 6/9 (67%) mid-term pregnant ewes infected with BTV-1
transmitted the virus to 14 of their foetuses (82%). These results
clearly demonstrate that, under the conditions in our experiment,
BTV-1 is able to induce transplacental infection.
Furthermore, the central nervous system lesions observed in the
BTV-1 infected foetuses were more severe than those seen in the
BTV-8 infected foetuses. Hydranencephaly or porencephaly was
observed in 8 of the BTV-1 infected foetuses, whereas in the BTV-
8 group, only slight vacuolation of the parenchyma was observed
in 3 foetuses.
Previous studies have demonstrated that BTV has a high affinity
for undifferentiated cells in the brain. BTV infection of the ovine
foetus around 50–60 days of gestation, a stage at which the
Table 3. Presence of Bluetongue infectious virus or RNA in foetal tissues: BTV-1 infected group+commingled control.
Foetal tissues
Umbilical cord blooda Spleen Cerebrum Cerebellum
Group Foetus number VI RT-qPCR VI VI VI
Uninfected control 78626.1 2 46.00 2 2 2
78626.2 2 46.00 2 2 2
78626.3 2 46.00 2 2 2
78626.4 2 46.00 2 2 2
78626.5 2 46.00 2 2 2
BTV1 infected 5537.1 2 46.00 2
5566.1 2 35.67 2
5585.1 2 46.00 2
78630.1 + 19.03 + + 2
78630.2 + 20.68 + + +
78631.1 + 19.06 + + +
78631.2 + 21.49 + + +
78631.3 + 24.58 2 + +
78634.1 + 22.45 + + +
78634.2 + 27.13 2 + 2
78649.1 + 22.45 2 + +
78649.2 + 22.54 + + +
78655.1 2 20.27 + + +
78655.2 + 20.15 2 + +
78655.3 + 25.81 2 + +
78656.1 + 21.95 + + 2
78656.2 + 18.93 + + +
Total no. of pos samples/no. of samples tested 13/17 14/17 9/17 14/14 11/14
aRT-qPCR result: Ct,30 = positive (in bold), 30#Ct,35 =doubtful, Ct$35 = negative.
Virus isolation (VI): + cpe detected; 2: no cpe detected. ns: no sample.
doi:10.1371/journal.pone.0081429.t003
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neuronal and glial precursor cells have not yet differentiated and
migrated to the cerebral cortex, led to destruction of the
undifferentiated neuronal precursor cells resulting in massive
necrosis and subsequent hydranencephaly [22,29,30]. Infection
around 75 days of gestation led to milder and more localized
lesions [29,31].The findings reported here demonstrate that BTV-
1 infection can induce severe necrotizing encephalitis even in
foetuses which are infected at 70–75 days of gestation.
Nonetheless, the findings in our experiment do not match the
experiences from the field: field investigations in 17 farms in Spain
(including 88 dams and 93 calves) could not demonstrate any case
of transplacental transmission in cattle upon natural infection with
BTV-1 [32]. Several factors might be suggested to explain the
difference between the findings in our experiment and in the field.
First of all, transplacental transmission of BTV is up to now
mainly associated with modified live vaccines, which contain virus
strains that have been attenuated through multiple -sometimes
over 50- in vitro passages. Bluetongue viruses, like other RNA
viruses, exist as a swarm of closely related sequence variants with
one or several dominant master sequences (quasispecies) [33].
Changes in the environment can lead to selection of sequence
variants with an improved fitness for the new environment. Hence,
passages in an artificial culture system -like ECE or cell culture-
may put the viruses through a genetic bottleneck, resulting in
selection of minor viral variants which favour growth in vitro. These
minor viral variants may also display phenotypical changes like
changes in virulence, tissue tropism and ability to cross the
placenta [34]. The viruses used in our experiment have been
derived from field strains. However, our strains have been isolated
in ECE and subsequently passaged once in Vero cells and once in
BHK cells to obtain a challenge virus stock. Although the total
number of passages was limited (three), and although for each
passage a different culture system was used, the in-vitro passages
might have resulted in a selection for minor viral variants that
facilitate transplacental transmission.
Contradictory to this speculation are the findings by Flanagan et
al. [21] and Roeder et al [35]. In their experiments with BTV-20
and BTV-11, a limited number of in vitro passages did not lead to
selection for minor viral variants which can cross the ruminant.
A second explanation might be the lack of sufficiently targeted
field data generated from larger surveys. Under natural circum-
stances, the transmission rate of BTV-1 might be low, and cases
might be missed if there is no specific surveillance focussed on
abortions or congenital malformations. The study in Spain, in
which transplacental transmission could not be demonstrated,
focussed on a limited number of cattle [32]; sheep were not
investigated. In Italy, evidence of transplacental transmission of
the BTV-2 and BTV-9 vaccine strains was only found after an
Figure 2. Localized cystic defect in the cerebral hemisphere
(right frontal lobe). Foetus 78630.2 (BTV-1 group, VI/PCR positive).
doi:10.1371/journal.pone.0081429.g002
Figure 3. Hydranencephaly. The cerebrum is transformed to fluid
filled sacs with only focal presence of cerebral tissue at the periphery.
Foetus 78631.3 (BTV-1 group, VI/PCR positive).
doi:10.1371/journal.pone.0081429.g003
Figure 1. Normal foetal brain with normally developed
cerebral gyri. Foetus 78654.2 (BTV-8 group, VI/PCR positive).
doi:10.1371/journal.pone.0081429.g001
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extensive retrospective study in sheep, cattle, goats and buffalo
[24].
A third explanation for the difference in findings might be the
design of our experiment. The virus dose (4.0 log10 TCID50) and
injection volume (10 ml) chosen for our experiment differ
substantially from the dose and volume delivered by the bite of
a Culicoides midge. The design of our experiment was chosen not to
closely mimic natural infections; it was based on previous
experiments that were successful in inducing transplacental
transmission in a limited number of animals [26,36,37].
Figure 4. Incidence ratio of microscopic findings. Incidence of lesion per number of foetuses for the BTV-8 positive foetuses (n = 14), BTV-1
positive foetuses (n = 14) and BTV negative foetuses (n = 23).
doi:10.1371/journal.pone.0081429.g004
Figure 5. Meningitis. Increase of meninges thickness (A) due to
mononuclear infiltrate, necrosis (arrow) and presence of giant
cells(circle). Cerebrum (10610) of foetus 78649.1 (BTV-1 group, VI/PCR
positive).
doi:10.1371/journal.pone.0081429.g005
Figure 6. Mononuclear inflammatory infiltrates (circles). Cere-
brum (4610) of foetus 78649.1 (BTV-1 group, VI/PCR positive).
doi:10.1371/journal.pone.0081429.g006
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Infectious BTV-1 was detected in the blood and spleen samples
of control ewe 78626. The timing of the first detection of BTV
RNA (at 21 dpi) differed significantly from the BTV-1 inoculated
ewes, which proves it unlikely that the ewe had accidentally been
injected with BTV-1. The experiment was conducted during the
vector free period in the winter of 2012, in insect secure isolation
facilities. The only possibility for an insect to enter the isolation
rooms was at the time of introduction of the ewes. However, the
chance that a midge would enter the facilities in mid-winter,
survive the cyfluthrin treatment and transmit BTV-1 to the
controls is effectively zero. Therefore, the control ewe most likely
was infected via direct contact. Vector-free horizontal transmission
has been described previously for BTV-8 [26,38,39], and more
recently for BTV-26 [40].
According to the Scientific Opinion of the Panel on Animal
Health and Welfare of the European Food Safety Authority, there
is no evidence that transplacental transmission of other serotypes
than 8 occurs in regions where no modified live vaccines have
been used. Based on this opinion, precautionary measures to
prevent the spread of BTV by pregnant animals are restricted to
BTV-8 [41]. In our experiments, we have irrevocably shown that
under certain circumstances, BTV-1 can cross the placenta and
infect the foetus, with severe pathological consequences. The
viruses used in our experiment were cultured in vitro; extrapolation
to the natural situation should therefore only be done with great
caution. Yet, Bonneau et al (2010) [33] demonstrated that
Culicoides feeding on low viraemic sheep can also result in fixing
of a new genotype by founder effect. Therefore, more research
comparing unpassaged and in vitro grown material is needed to
better understand the drivers behind transplacental transmission of
BTV.
Conclusion
Both BTV-8 and BTV-1 were able to cross the placenta in 70–
75 days pregnant ewes and infect the foetus. The incidence of
transplacental transmission of BTV-1 was higher than that of
BTV-8. BTV-1 infection induced a severe encephalopathy in 8/14
Figure 7. Necrosis and liquefaction of cerebral tissue. Cerebrum
(10610) of foetus 78655.1 (BTV-1 group, VI/PCR positive).
doi:10.1371/journal.pone.0081429.g007
Figure 8. Necrosis, presence of multiple multinucleated giant
cells (arrows), the lower one with vacuoles. Cerebrum (40610) of
foetus 78655.1 (BTV-1 group, VI/PCR positive).
doi:10.1371/journal.pone.0081429.g008
Figure 9. Normally developed cerebral tissue. Cerebrum (10610)
of foetus 78626.3(control of BTV-1 group, VI/PCR negative).
doi:10.1371/journal.pone.0081429.g009
Figure 10. Ballooning degeneration of epithelium (arrow) and
congestion of blood vessels. Plexus choroideus (20610) of foetus
78631.3 (BTV-1 group, VI/PCR positive).
doi:10.1371/journal.pone.0081429.g010
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infected foetuses, whereas in the BTV-8 infected foetuses, only
mild cerebral vacuolation was observed in 3/12 foetuses.
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